SHS is a venture capital firm that provides young high-tech companies with venture capital and actively supports them in establishing and developing their businesses.
SHS invests in young high-growth companies in German-speaking countries (D-A-CH market) in the life sciences/healthcare arena (medical technology, diagnostics, drug development [special situations only], platform and production technologies). The companies we invest in must have market-ready products or technologies.
SHS' seasoned, successful management team has an excellent track record.
Our unique risk management approach enables us to handle market volatility, yielding attractive returns for investors and entrepreneurs.